Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 10, 2011

View Archived Issues

TSRL discloses preclinical data on neuraminidase inhibitor prodrugs

GSK FLAP inhibitor attenuates allergen-induced asthma responses in phase II trials

MRI technique may aid in differentiating Gulf War illness variants

Study identifies SNPs associated with severity of A/H1N1/2009 influenza in children

Protalix Biotherapeutics patents novel cross-linked multimeric proteins for Gaucher's disease

Promising phase III data disclosed on VX-770 in CF

AXL-1717 benefits patients with advanced-stage NSCLC in phase I trial

Scientists in Taiwan identify miRNA signature associated with incidence of oral cancer

Amgen discloses novel series of beta-secretase 1 inhibitors

Novel prostanoid DP1 receptor antagonists synthesized by Sanofi

New TRPA1 channel antagonists presented by Glenmark Pharmaceuticals

Novel agents for bacterial infections claimed

New SSAO inhibitors described by Proximagen

FDA approves Merck & Co.'s Juvisync

Epix Pharmaceuticals and Amgen S1P1 program assets to be offered for sale

BAY-1017858 shows promise in vitro and in vivo

Abbott enrolls first patients in EXCEL trial evaluating Xience everolimus-eluting stents

FDA and Starpharma agree on phase III program for VivaGel

Victoza launched in China

Trimel Pharmaceuticals provides update on phase II Vibro-Tactile Stimulation trial

Hybrigenics and Servier sign license and collaboration agreement covering multiple fields

Adherex to discuss development of sodium thiosulfate with FDA advisory committee

Biotron provides results from preliminary analysis of BIT-225 study

Paladin Labs completes Labopharm acquisition

Combivent Respimat approved in U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...